Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Age is No Longer a Barrier to Hepatitis C Treatment with Newer DAAs
A recent study finds that the use of sofosbuvir-based direct-acting antivirals for HCV treatment was effective and well-tolerated in elderly patients.
Glecaprevir & Pibrentasvir Yield High Cure Rates in Non-cirrhotic Patients with HCV Genotype 1-6
A new study demonstrates that the drug regimen consisting of glecaprevir plus pibrentasvir for non-cirrhotic patients with HCV genotype 1-6 is safe and effective.
Treatment as Prevention: A Comprehensive Approach to Hepatitis C Virus in Persons Who Inject Drugs
With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.
Mavyret Approved for Patients with Chronic HCV Genotypes 1-6 Without Cirrhosis
The US Food and Drug Administration approved Mavyret for adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis or with mild cirrhosis.
HBV Reactivation More Severe in HBV/HCV Coinfected Patients Receiving DAA Therapy
A recent study finds that HBV reactivation occurs earlier and is more severe in HBV/HCV coinfected patients treated with DAA therapy compared with patients treated with IFN-based therapy.
New Study Evaluates Risk of HBV Reactivation in Veterans Receiving DAA Therapy
A new study published in the Journal of Hepatology evaluates the risk of HBV reactivation in veterans receiving direct-acting antiviral therapy.
HCV Patients Who Reach SVR With DAA Drugs Show Reduced Risk of Liver Cancer
Study finds that hepatitis C patients who had reached sustained virologic response using direct-acting antiviral drugs show a considerably reduced risk of the most common type of liver cancer.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.